A lawyer for the U.S. Chamber of Commerce on Friday urged a federal judge to block President Joe Biden's administration from implementing a new program that would let Medicare negotiate prices with ...
The Chamber of Commerce urged a federal judge on Friday to stop the new Medicare drug price negotiation program before Oct. 1 ...
Drug companies challenging the law in court could still have several chances to stop the program before next year's election.
PhRMA, a leading drug industry trade group, and the US Chamber of Commerce have also filed suits. More on Medicare drug pricing: Medicare lists first ten drugs selected for pricing negotiations ...
As we have covered in previous articles here, the new authority Congress provided to the Department of Health and Human Services (HHS) under the Inflation Reduction Act (IRA) to directly negotiate ...
Aug 31 (Reuters) - Drugmakers challenging a Biden administration program requiring them to negotiate with Medicare over the prices of selected costly drugs may not have a clear legal precedent on ...
After spending two decades in Washington, D.C., working for politicians, interest groups and one of the world’s largest telecommunications companies, Vanessa Green Sinders was ready to settle down, ...
The Biden administration has picked the first 10 high-priced prescription drugs subject to federal price negotiations, taking a swipe at the powerful pharmaceutical industry.
WORCESTER - The Worcester Regional Chamber of Commerce is spearheading an online news website, the Worcester Guardian. The chamber is pitching the website as "free civically oriented journalism on ...
The Metropolitan Savannah Hispanic Chamber of Commerce is holding its first parade and festival for Hispanic Heritage Month since 2017 on Saturday. President Alfonso Ribot said his goal is to ...
Japanese drugmaker Astellas (OTCPK:ALPMF) has withdrawn a federal lawsuit that challenged the US government’s right to negotiate drug prices for its Medicare program, but maintained the newly ...
The Biden administration has picked the first 10 high-priced prescription drugs subject to federal price negotiations, taking a swipe at the powerful pharmaceutical industry. It marks a major ...
